Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
Provided By GlobeNewswire
Last update: Jul 2, 2025
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025
Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement
Read more at globenewswire.com
